Neuracle Science Co., Ltd.;KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
发明人:
Bongcheol KIM,Eun Bee CHO,Dong Sik KIM,Jae-Keun LEE,Soon-gu KWON,Jae Young SEONG,Juwon SHIM,Tae Woo KIM,Shin-hyuk KANG
申请号：
US16626625
公开号：
US20200223914A1
申请日:
2018.06.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to promote a blood vessel normalization and treat a disease (e.g., cancer) in a subject in need thereof, e.g., by promoting a blood vessel normalization.
